Perspective Therapeutics (CATX) Return on Capital Employed [ROCE] (2011 - 2026)
Perspective Therapeutics (CATX) posted Return on Capital Employed [ROCE] of -33.38% for Q2 2026, up 2.28 percentage points from -35.66% a year earlier and up 4.54 percentage points from the prior quarter.
Powered by 
Analysis
Perspective Therapeutics (CATX) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends
For FY2025, Perspective Therapeutics' Return on Capital Employed [ROCE] came in at -41.24%, up 3.91 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] shows a five-year change of +5.19 percentage points (FY2020 to FY2025).
- In prior years, Perspective Therapeutics' Return on Capital Employed [ROCE] was -45.16% in FY2024 (+20.53 pp), -65.69% in FY2023 (-50.77 pp), -14.91% in FY2022 and -9.13% in FY2021 (+37.31 pp).
- The Q2 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q1 2025.
- On a year-over-year basis, Return on Capital Employed [ROCE] increased in three of the last eight quarters, with an average year-over-year change of -5.30 percentage points.
- The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q4 2024, with a gain of 20.12 percentage points; the weakest was Q4 2023, with a drop of 26.98 percentage points.
- According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -37.92% (Q1 2026), -43.66% (Q4 2025) and -41.40% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 11.86% |
| 10 | Perspective Therapeutics | 311.46 Mn | 311.46 Mn | - | -33.38% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -33.38% |
| Mar 31, 2026 | -37.92% |
| Dec 31, 2025 | -43.66% |
| Sep 30, 2025 | -41.40% |
| Jun 30, 2025 | -35.66% |
| Mar 31, 2025 | -30.91% |
| Dec 31, 2024 | -26.12% |
| Sep 30, 2024 | -15.98% |
| Jun 30, 2024 | -15.15% |
| Mar 31, 2024 | -25.45% |
| Dec 31, 2023 | -46.24% |
| Sep 30, 2023 | -27.15% |
| Jun 30, 2023 | -20.44% |
| Mar 31, 2023 | -18.58% |
| Dec 31, 2022 | -13.17% |
| Sep 30, 2022 | -15.68% |
| Jun 30, 2022 | -11.73% |
| Mar 31, 2022 | -9.85% |
| Dec 31, 2021 | -8.72% |
| Sep 30, 2021 | -7.39% |
API Access
Perspective Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CATX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "CATX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CATX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();